Animal IV Product Recalled Due to Potential Presence of Fiber-Like Particles

Injected animals may suffer from blood clots and stroke, potentially resulting in death.

The U.S. Food and Drug Administration (FDA) in White Oak, Md., on June 5, 2023. Madalina Vasiliu/The Epoch Times

An intravenous therapy product used in animals has been recalled nationwide in the United States following concerns about the potential presence of particulate matter, according to the U.S. Food and Drug Administration (FDA).

Nebraska-based Nova-Tech Inc. is withdrawing one lot of its Lactated Ringers Injection after determining that the product could potentially be contaminated with “fiber-like visible particles,” the company said in a March 4 recall announcement published by the FDA.